Aacr Kras Meeting
TrovaGene Release: Large Clinical Study Demonstrates High
Read more
KRAS Mutation in cfDNA Linked to Response to Chemo in
Read more
Heterogeneous pathway activation and drug response modelled
Read more
Pal LB-087 AACR 2018 Poster upload 4-11-18
Read more
The New Horizons in Cancer Research Conference of AACR ended
Read more
3-V Biosciences to Present Data at the AACR 2017 Annual
Read more
KRAS as a Therapeutic Target | Clinical Cancer Research
Read more
March Editors' Picks from AACR Journals - CANCER RESEARCH
Read more
Epigenetic loss of SLIT2 leads to an autocrine-to-paracrine
Read more
Dr Heymach on New KRAS Subsets in Lung Cancer
Read more
2016 AACR Annual Meeting Presentations Highlight Advances in
Read more
Spotlight — Kevin Haigis Laboratory
Read more
Posters and Presentations – eFFECTOR
Read more
AACR 2017 - 228cm(w)x110cm(h)_FINAL
Read more
Structure-Based Drug Discovery of MRTX1257, a Selective
Read more
Heterogeneous pathway activation and drug response modelled
Read more
Presentations at the AACR Annual Meeting to Highlight
Read more
Pharmacological Induction of RAS-GTP Confers RAF Inhibitor
Read more
The prognostic value of TP53 mutations in oesophageal
Read more
AACR Annual Meeting 2016 Program Guide PDF Tuesday, April
Read more
Amgen Announces New Clinical Data Evaluating Novel
Read more
Molecular Radiation Biology News: Radiation Oncology - UT
Read more
KRAS mutation testing for predicting response to anti-EGFR
Read more
Cells | Free Full-Text | Whole Transcriptome Analysis
Read more
Amgen Announces New Clinical Data Evaluating Novel
Read more
33rd Annual Meeting & Pre-Conference Programs of the Society
Read more
Kras/Src tumor cells exhibit Src dependency (a) Effect of
Read more
AACR 2016 | Sandra and Edward Meyer Cancer Center
Read more
RAS Synthetic Lethal Screens Revisited: Still Seeking the
Read more
Whole-exome sequencing of plasma cell-free DNA portrays the
Read more
Conference Highlights: AACR 2019 | Physician's Weekly
Read more
IL22 Promotes Kras-Mutant Lung Cancer by Induction of a
Read more
Posters and Presentations – eFFECTOR
Read more
AACR 2017 - 228cm(w)x110cm(h)_FINAL
Read more
THIRD CRI-CIMT-EATI-AACR INTERNATIONAL CANCER I
Read more
AACR Annual Meeting Late-Breaking Abstract #1: Innovative St
Read more
2019 Symposium - UC San Diego Moores Cancer Center Industry
Read more
Media Gets Sneak Peek at Annual Meeting Scientific
Read more
KRAS G12C Inhibitor (MRTX849) - Mirati Therapeutics, Inc
Read more
AACR 2017 - William Kim on Onco-GPS to guide precision
Read more
VIDEO: Vitamin C may kill cancer cells in KRAS –mutant
Read more
MM-310 Maximizes the Delivery and Local Activation of a
Read more
WCLC 2019: Daiichi Sankyo to Present Results from First-in
Read more
Co-occurring genomic alterations in non-small-cell lung
Read more
RAS Initiative Meetings and Videos - National Cancer Institute
Read more
RainDance Blog | Tackling Cancer at AACR | RainDance
Read more
PDF) Analysis of KRAS/NRAS Mutations in a Phase III Study of
Read more
Novel first-in-class FLIP inhibitors for the treatment of
Read more
Assessing therapeutic responses in Kras mutant cancers using
Read more
James L Gulley MDPhD on Twitter: "And a separate triple
Read more
2016 AACR Annual Meeting presentations highlight advances in
Read more
Genomic Applications in Gynecologic Malignancies | SpringerLink
Read more
Other Driver Mutations: cMET, B-RAF, RET, NTRK
Read more
Oncotarget | Base excision repair-mediated resistance to
Read more
PDX Finder team at the AACR Annual Meeting 2019 in Atlanta
Read more
Cells | Free Full-Text | Whole Transcriptome Analysis
Read more
Amgen unveils its KRas inhibitor in human clinical trials
Read more
AACR 2016: Cancer Immunotherapy and Beyond | Technology Networks
Read more
NEWS | Epithelial Plasticity | Baltimore | Tran Laboratory
Read more
IL22 Promotes Kras-Mutant Lung Cancer by Induction of a
Read more
Edward Chu, MD UPMC Hillman Cancer Center - ppt download
Read more
Abstract painter: ASCO's KRAS rollouts red Haring? Early
Read more
Crazy about KRAS: Breaking down the hype of a hot new cancer
Read more
Heterogeneous pathway activation and drug response modelled
Read more
Quantitative and multiplexed in vivo functional cancer
Read more
InteRNA Demonstrates Preclinical Proof-of-Concept for Lead
Read more
American Association for Cancer Research Annual Meeting
Read more
Presenting NTRK Reference Materials for Global Assay
Read more
Sysmex Inostics Competitors, Revenue and Employees - Owler
Read more
